Viewing Study NCT01635803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-01-25 @ 6:49 PM
Study NCT ID: NCT01635803
Status: UNKNOWN
Last Update Posted: 2015-07-01
First Post: 2012-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinal Vein Occlusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bevacizumab View
None ranibizumab View
None retinal vein occlusions View
None randomized clinical trial View
None Macular edema View